Cargando…

Toxicity of Therapy with Sm-153-EDTMP: To What Extend can it be Related to the Tumor Type?

Detalles Bibliográficos
Autores principales:	Świętaszczyk, Cyprian, Kobus-Błachnio, Katarzyna, Pilecki, Stanisław E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729024/ https://www.ncbi.nlm.nih.gov/pubmed/26912987 http://dx.doi.org/10.4103/1450-1147.167603

Ejemplares similares

Bone Scintigraphy Hot-Spot in Projection to Rib and Kidney: Role of Single Photon Emission Computer Tomography/Computer Tomography in Distinguishing a Urine Collection in Renal Calyx from a Metastasis to Rib
por: Świętaszczyk, Cyprian, et al.
Publicado: (2015)

Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis
por: Ayati, Narjess, et al.
Publicado: (2013)

To what extent can diverse types of liver lesions mimic hemangiomas? A retrospective quantitative analysis of masses found to be positive in SPECT/CT with labeled blood cells – a preliminary report
por: Świętaszczyk, Cyprian, et al.
Publicado: (2013)

Comparison of Tc-99m MDP and Sm-153 EDTMP bone scan
por: Ramachandran, Krishnakumar, et al.
Publicado: (2011)

Enhanced Accumulation of Bone Seekers at Superior Lateral Orbital Margin: Potential Origin
por: Świętaszczyk, Cyprian, et al.
Publicado: (2014)

Beyond Palliation: Therapeutic Applications of (153)Samarium-EDTMP
por: Wilky, Breelyn A., et al.
Publicado: (2013)

Comparative Therapeutic Efficacy of (153)Sm-EDTMP and (177)Lu-EDTMP for Bone Pain Palliation in Patients with Skeletal Metastases: Patients’ Pain Score Analysis and Personalized Dosimetry
por: Sharma, Sarika, et al.
Publicado: (2017)

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases
por: Lam, Marnix G. E. H., et al.
Publicado: (2007)

Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP
por: Kassi, Eva, et al.
Publicado: (2017)

Radionuclide Treatment with 153Sm-EDTMP is Effective for the Palliation of Bone Pain in the Context of Extensive Bone Marrow Metastases: A Case Report
por: Kairemo, Kalevi, et al.
Publicado: (2014)

Effects of low-dose capecitabine on Samarium-153-EDTMP therapy for painful bone metastases
por: Barai, Sukanta, et al.
Publicado: (2015)

Congenital vascular malformations in scintigraphic evaluation
por: Pilecki, Stanisław, et al.
Publicado: (2014)

Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
por: Joob, Beuy, et al.
Publicado: (2014)

The Level of Europium-154 Contaminating Samarium-153-EDTMP Activates the Radiation Alarm System at the US Homeland Security Checkpoints
por: Najeeb Al Hallak, Mohammed, et al.
Publicado: (2009)

Samarium-153-EDTMP (Quadramet(®)) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial
por: Heery, Christopher R., et al.
Publicado: (2016)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [(153)Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022)

Synthesis and Ready to Use Kit Formulation of EDTMP for the Preparation of 177Lu-EDTMP as a Bone Palliation Radiopharmaceutical
por: Mercanoglu, Guldem, et al.
Publicado: (2023)

The influence of Sm-153 therapy on bone marrow function
por: Małkowski, Bogdan, et al.
Publicado: (2016)

sup 8 sup 9 Sr and sup 1 sup 5 sup 3 Sm-EDTMP therapy of disseminated skeletal metastasis
por: Zhang Jun Ning, et al.
Publicado: (2001)

Dosimetric implications of the potential radionuclidic impurities in (153)Sm-DOTMP
por: Wendt, Richard E., et al.
Publicado: (2022)

The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and $^{225}$Ac in tumor bearing mice
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1996)

Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
por: Keeling, A. A., et al.
Publicado: (1989)

Systemic Radiopharmaceutical Agents (Sm-153) may be Dangerous in Hepatacellular Carcinoma
por: Keskin, Onur, et al.
Publicado: (2015)

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021)

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021)

Production, Quality Control and Pharmacokinetic Studies of (166)Ho-EDTMP for Therapeutic Applications
por: Bahrami-Samani, Ali, et al.
Publicado: (2010)

Development of (153)Sm-DTPA-SPION as a theranostic dual contrast agents in SPECT/MRI
por: Gholami, Amir, et al.
Publicado: (2016)

Fentanyl can be mitochondrion -toxic depending on dosage and cell type
por: Finsterer, Josef, et al.
Publicado: (2019)

Disability and Happiness in Iran: What Can We Do?
por: SOLTANI, Shahin, et al.
Publicado: (2018)

Preparation and Quality Control of the [(153)Sm]-Samarium Maltolate Complex as a Lanthanide Mobilization Product in Rats
por: Naseri, Zohreh, et al.
Publicado: (2011)

RADIOACTIVE CEMENT OF PMMA AND HAP-Sm-153, Ho-166, OR RE-188 FOR BONE METASTASIS TREATMENT
por: Montaño, Carlos Julio, et al.
Publicado: (2019)

Scutellarin Loaded on Ultradeformable Nanoliposome Scutellarin EDTMP (S-UNL-E) Promotes Osteogenesis in Osteoporotic Rats
por: Teng, Minhua, et al.
Publicado: (2022)

Radiation Protection in Cardiovascular Interventions: What Can We Do?
por: Liu, Qiang, et al.
Publicado: (2015)

Can we still do something-and what? - for a seemingly missing syndrome?: “Yes we can”
por: Piumelli, Raffaele, et al.
Publicado: (2019)

Selective killing of circulating tumor cells prevents metastasis and extends survival
por: Kim, Yi Rang, et al.
Publicado: (2018)

Lung cancer in the era of COVID-19: what can we expect?
por: Araujo-Filho, Jose de Arimateia Batista, et al.
Publicado: (2020)

Finasteride and Floppy Iris Syndrome: What Role Can the Dermatologist Play?
por: Calvao, Joana, et al.
Publicado: (2022)

Effectiveness of Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva): First Experience
por: Rasulova, Nigora, et al.
Publicado: (2013)

[(153)Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma
por: Kratochwil, Clemens, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jg6aflm7eb0l6m6un86aslqvvh